Early initiation of beta blockade in heart failure: issues and evidence.
about
Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers.Clinical trial experience with CA4P anticancer therapy: focus on efficacy, cardiovascular adverse events, and hypertension management.
P2860
Early initiation of beta blockade in heart failure: issues and evidence.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Early initiation of beta blockade in heart failure: issues and evidence.
@ast
Early initiation of beta blockade in heart failure: issues and evidence.
@en
type
label
Early initiation of beta blockade in heart failure: issues and evidence.
@ast
Early initiation of beta blockade in heart failure: issues and evidence.
@en
prefLabel
Early initiation of beta blockade in heart failure: issues and evidence.
@ast
Early initiation of beta blockade in heart failure: issues and evidence.
@en
P2860
P1476
Early initiation of beta blockade in heart failure: issues and evidence.
@en
P2093
Randall E Williams
P2860
P304
520-8; quiz 529-30
P356
10.1111/J.1524-6175.2005.04273.X
P577
2005-09-01T00:00:00Z